Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,268,030
+$3,268,030 QoQ
Shares Held
56,200
Ownership
0.058%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Derivatives in XENE
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$9,990,170
PutShares
171,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026LMR Partners LLP holds $224,816,570 across 60 Biotechnology names. XENE ranks #15 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
74,661 | $24,703,084 | |
| 2 | ACLX |
Arcellx, Inc.
|
212,495 | $24,398,675 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
400,000 | $21,088,000 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
324,939 | $18,355,804 | |
| 5 | ARGX |
Argenx SE
|
23,488 | $17,152,112 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
403,622 | $16,237,713 | |
| 7 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,049,700 | $15,178,662 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
130,000 | $12,642,500 |
All Filings in XENE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,990,170 | 171,800 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $3,268,030 | 56,200 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,982,956 | 155,800 | Put | Sole | 2026-02-17 | |
| 2024-12-31 | $1,907,785 | 48,668 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,916,059 | 48,668 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,897,565 | 48,668 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,095,157 | 48,668 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,125 | 958 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $4,541,516 | 98,600 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $854,000 | 25,000 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $1,971,500 | 50,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,371,697 | 65,698 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,042,000 | 100,000 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||